home / stock / glpg / glpg articles

GLPG Articles, Galapagos NV - From 12/07/23

Stock Information
Company Name: Galapagos NV
Stock Symbol: GLPG
Market: NASDAQ
Website: glpg.com
Menu
GLPG GLPG Quote GLPG Short GLPG News GLPG Articles GLPG Message Board
Get GLPG Alerts

News, Short Squeeze, Breakout and More Instantly...
Galapagos to Host KOL Event on December 10, 2023, at 11:00 AM PST to discuss new data presented at ASH 2023 | Benzinga

Mechelen, Belgium; 6 December 2023, 22:01 CET; Galapagos NV ((Euronext &amp, NASDAQ:GLPG) today announced that it will host a Key Opinion Lead...
Galapagos reports third quarter 2023 results and releases new encouraging data from CAR-T studies for presentation at ASH 2023 | Benzinga

First nine months 2023 key financials: Group revenues of €448.9 million Jyseleca® net sales of €82.1 million Cash and current financi...

Galapagos concludes strategic evaluation and signs letter of intent to transfer Jyseleca® business to Alfasigma | Benzinga

Transaction would enable Galapagos to realize considerable annualized savings and accelerate its pipeline focused on developing transformational ...

Galapagos appoints Simon Sturge to its Board of Directors | Benzinga

Mechelen, Belgium; 19 September 2023, 22:01 CET; Galapagos NV ((Euronext &amp, NASDAQ:GLPG) today announced that during its meeting of 19 Sept...
Galapagos announces start of Phase 2 study with selective TYK2 inhibitor, GLPG3667, in patients with active systemic lupus erythematosus | Benzinga

GLPG3667 is an investigational, novel, oral, reversible, and selective tyrosine kinase 2 (TYK2) inhibitor   GLPG3667 is currently in developmen...

Previous 10 Next 10